— Know what they know.
Not Investment Advice
Also trades as: 0JZ2.L (LSE) · $vol 0M

MASI NASDAQ

Masimo Corporation
1W: +0.6% 1M: +0.9% 3M: +2.5% YTD: +41.2% 1Y: +7.8% 3Y: +9.6% 5Y: -13.9%
$179.95
Last traded 2026-06-12 — delisted
NASDAQ · Healthcare · Medical - Devices · $9.4B mcap · 44M float · 2.43% daily turnover · Short 49% of daily vol

Cash Flow Trends

Operating Cash Flow
$218M +10.6% ▲
5Y CAGR: +0.6%
Capital Expenditures
$19M +62.0% ▲
5Y CAGR: -24.7%
Free Cash Flow
$198M +36.1% ▲
5Y CAGR: +8.6%
Dividends Paid
$0 +0.0% ▲
Buybacks
$364M +0.0% ▲
Net Change in Cash
$26M +97.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$230M$144M$82M-$305M-$152M
Depreciation & Amort.$36M$136M$98M$103M$39M
Stock-Based Comp.$45M$48M$7M$42M$36M
Change in Working Capital-$32M-$262M-$71M-$11M-$90M
Other Non-Cash Items$1M$3M$14M$406M$372M
Operating Cash Flow$265M$29M$94M$196M$218M
— Investing Activities —
Capital Expenditures-$26M-$53M-$44M-$20M-$19M
Acquisitions (Net)$0-$1000M$8M$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$12M-$5M-$45M-$31M$294M
Investing Cash Flow-$38M-$1.1B-$81M-$51M$275M
— Financing Activities —
Net Debt Issuance$0$948M-$51M-$139M-$208M
Stock Repurchased-$129M-$402M$0$0-$364M
Dividends Paid$0$0$0$0$0
Other Financing-$17M-$35M-$13M-$12M-$21M
Financing Cash Flow-$122M$520M-$57M-$126M-$521M
Net Change in Cash$103M-$539M-$41M$13M$26M
Cash End of Period$748M$210M$168M$181M$152M
Free Cash Flow$230M-$27M$6M$145M$198M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms